Berberine and Tinospora cordifolia exert a potential anticancer effect on colon cancer cells by acting on specific

Annalisa Palmieri1, Luca Scapoli1, Anastasia Iapichino1

  • 1Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.

Insights

Berberine (BBR), a natural compound, shows anticancer potential by down-regulating key genes involved in cell proliferation and differentiation. Its presence in Tinospora cordifolia extract contributes significantly to the plant's antiproliferative effects.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Cancer Research

Background:

  • Berberine (BBR) is a natural compound with demonstrated potential for antitumor activity.
  • BBR influences multiple cell signaling pathways crucial for cancer progression, including proliferation, differentiation, and epithelial-mesenchymal transition.

Purpose of the Study:

  • To investigate the anticancer mechanisms of BBR.
  • To compare the effects of purified BBR with Tinospora cordifolia extract on gene expression in colon cancer cells.

Main Methods:

  • Real-time polymerase chain reaction (PCR) was used to quantify the expression of 44 selected genes.
  • Human colon adenocarcinoma (HCA-7) cells were treated with purified BBR and Tinospora cordifolia extract.
  • Gene expression analysis was performed at different time points and dosages.

Main Results:

  • Berberine treatment led to a time- and dose-dependent down-regulation of 33 genes.
  • Affected genes were involved in cell cycle, differentiation, and epithelial-mesenchymal transition.
  • Similar trends in gene expression were observed for both purified BBR and the plant extract.

Conclusions:

  • Berberine significantly impacts cancer-related gene expression, supporting its role in antiproliferative activity.
  • The findings indicate that BBR is a major contributor to the anticancer effects of Tinospora cordifolia extract.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K